GOVA is a Helsinki-based food-biotech start-up offering proprietary molecular encapsulation technology that prevents crystallization and enhances the performance of natural sweeteners. The solution enables B2B food and beverage manufacturers to replace sugar with stable, high-concentration sweetener alternatives that maintain texture, bulk, heat stability, and shelf life without unpleasant aftertaste.
GOVA is a Helsinki-based food-biotech start-up that has developed proprietary molecular encapsulation technology to improve the performance of natural sweeteners used in sugar-free food and beverage products. The technology addresses long-standing industry challenges such as aftertaste, inconsistent sweetness levels, poor stability, digestive discomfort, and texture degradation. By encapsulating sweetener molecules, GOVA enables manufacturers to replace traditional sugar with healthier alternatives that retain essential functional properties including texture, bulk, heat stability, and shelf life, while significantly reducing calories and sugar content.
The solution offers a cleaner-label approach compared to conventional blending methods, which typically rely on complex mixtures of multiple ingredients and preservatives to mimic sugar's performance. GOVA's technology is validated for both EU and US markets and is versatile enough to integrate into applications such as baked goods, beverages, dairy, confectionery, and condiments like ketchup. This positions GOVA to help brands tap into the growing consumer demand for healthier, lower-calorie products without sacrificing taste or quality.
GOVA has completed initial internal testing with strong results, leading to two patent filings. The company holds a full R&D contract with a PhD researcher specializing in crystallization from Aalto University and collaborates with a PhD researcher in Erythritol studies at KU Leuven University, who is validating the impact of natural sweeteners on the brain compared to artificial sweeteners. An R&D roadmap is scheduled to begin September 1st, starting with molecule-level analysis of sweetener transitions, followed by end-product testing, piloting with two clients under letters of intent, and pursuit of corporate licensing agreements with major food manufacturers. The company is actively seeking research funding to accelerate validation in end products and extend concentration and shelf-life capabilities.
GOVA is a Helsinki-based food-biotech company that has developed proprietary molecular encapsulation technology to improve the performance of sugar and sweeteners. By encapsulating these ingredients, the company enables food and beverage manufacturers to replace traditional sugar with healthier alternatives that maintain essential functional properties like texture, bulk, heat stability, and shelf life, while achieving significant reductions in calories and sugar content without an unpleasant aftertaste. This technology offers a cleaner label solution compared to conventional blending methods, which often rely on complex mixtures of multiple ingredients and preservatives to mimic sugar's performance.
This innovation addresses the growing consumer demand for healthier, lower-calorie food and beverage products without sacrificing taste or quality. By providing drop-in replacements, such as hybrid sugar blends and encapsulated liquid alternatives, GOVA helps manufacturers tackle challenges related to obesity and diabetes while simplifying their production processes. The company's technology is validated for both EU and US markets and is versatile enough to be integrated into various applications, including baked goods, beverages, dairy, and confectionery, allowing brands to offer healthier product portfolios that appeal to health-conscious consumers.